Aware, Inc. stock price, AWRE

Aware, Inc. stock chart:



Aware, Inc. close price: 4.65

Stock price forecast:

UP TO +5.16%
Target: 4.89

Total forecasts: 82
Reached: 16 (19.51%)

Total Win: 4.77 (78.18%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90831720.48%5.040.99%318.40-11.50-3.61%-6.46-1.53%
302300.00%0.000.00%107.35-0.40-0.37%-0.40-0.37%
141500.00%0.000.00%69.90-0.15-0.21%-0.15-0.21%
7800.00%0.000.00%37.25-0.05-0.13%-0.05-0.13%

Showing 1-10 of 533 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-04-234.654.90000-00-00
2017-04-224.654.910000-00-00
2017-04-214.654.920000-00-00
2017-04-204.654.930000-00-00
2017-04-194.64.910000-00-00
2017-04-184.654.960000-00-00
2017-04-174.74.970000-00-00
2017-04-164.74.980000-00-00
2017-04-154.74.990000-00-00
2017-04-144.750000-00-00

Aware, Inc. latest news:


  • 04/17/2017 09:19:22

    Blackstone to buy EagleClaw Midstream for about $2 billion

    (Reuters) - EagleClaw Midstream Ventures LLC, the largest privately held operator of pipelines and processing facilities in West Texas' Delaware Basin, said it agreed to be bought by funds managed by Blackstone Group LP for about $2 billion.

  • 04/17/2017 06:25:16

    Blackstone PE business to pay $2 billion to buy EagleClaw Midstream Ventures

    Blackstone Group LP's energy-focused private-equity business, Blackstone Energy Partners and Blackstone Capital Partners agreed Monday to buy EagleClaw Midstream Ventures LLC for $2 billion in cash. The deal is expected to close by the end of July, and includes $1.25 billion in debt financing, provided by Jefferies LLC. EagleClaw is a privately-held midstream operator in the Permian's Delaware Basin in West Texas. EagleClaw's management and nearly all of the company's employees will remain in their jobs, the companies said. Blackstone's stock, which was inactive in premarket trade, has tacked on 6.8% year to date, while the S&P 500 has gained 4%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/12/2017 09:38:15

    Despite Little Guidance, Lenders Monitor Ancillary Sales

    Lenders are aware that increased regulatory scrutiny of ancillary products, such as GAP insurance, is coming down the pipeline, but there’s little consensus among the Consumer Bankers Association’s Auto Finance Committee as to what aspect of these after-sale products should be monitored, said Robert Griffin, indirect lending manager at CommerceRead More

  • 04/11/2017 10:48:50

    AmTrust's stock plummets in active trade after WSJ report regarding government probe

    Shares of AmTrust Financial Services Inc. plummeted 22% in active trade toward a 3 1/2-year low in midday trade Tuesday, after the secret recordings used in a government probe into the insurer was highlighted in The Wall Street Journal. Volume spiked to nearly 15 million shares in recent trade, which was already more than four times the full-day average. An auditor at an accounting firm auditing AmTrust recorded conversations with colleagues in 2014, using a device disguised as a Starbucks gift card, on behalf of the Federal Bureau of Investigation and cooperating as a whistleblower with the Securities and Exchange Commission, the WSJ reported, citing people familiar with the matter. AmTrust responded Tuesday by saying it was "not aware of any such investigation, nor for that matter, has it ever been contacted by the FBI with respect to such an investigation. The stock has now plunged 32% over the past month, as the company said in March that its financial statements dating back to 2014 should be disregarded because of revenue recognition errors. In comparison, the SPDR S&P Insurance ETF has slipped 2.3% over the past month and the S&P 500 has eased 1%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/03/2017 11:20:44

    Democrats have enough votes to filibuster Gorsuch nomination

    Sen. Chris Coons of Delaware became the 41st Democrat to announce he'll join a filibuster against Judge Neil Gorsuch, President Donald Trump's nominee to the Supreme Court. The move means Democrats have enough votes to block Gorsuch -- but Senate Republicans may respond by triggering what is known as the nuclear option, or changing Senate rules to confirm him with a simple majority. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/23/2017 22:17:32

    Toshiba says not aware Westinghouse considering Chapter 11 filing

    TOKYO (Reuters) - Toshiba Corp said on Friday it was not aware that its U.S. nuclear unit Westinghouse was considering seeking protection from creditors, an option analysts say could put the entire TVs-to-construction conglomerate at risk if exercised now.

  • 02/13/2017 19:09:11

    Court-Ordered Sale of TransPerfect Translation Company Is Upheld

    A Delaware court affirmed a ruling stemming from a deadlock over the management of the privately held, New York-based business its feuding founders started in a college dorm room.

  • 02/13/2017 15:05:01

    Delaware Supreme Court upholds forced company sale

    Delaware's Supreme Court has upheld the court-ordered sale of a successful New York-based translation company after a judge concluded the relationship between the company's two co-founders and sole directors had devolved into "complete dysfunction."

  • 02/05/2017 22:18:05

    BRIEF-Eastern Outfitters files for chapter 11 bankruptcy

    * Eastern Outfitters Llc files for chapter 11 bankruptcy protection in Delaware court; lists assets and liabilities in $100-$500 million range - Court filing

  • 01/30/2017 17:15:18

    Teva shares fall as court invalidates patent infringement claims

    Teva Pharmaceutical Industries Ltd. shares fell in the extended session Monday after a court did not uphold patent infringement claims made by the company. Teva shares fell 10% to $31 after hours. The court sided with Mylan NV , which claimed the patents in question were invalid. Mylan shares rose 0.7% to $36.60. The ruling from the U.S. District Court for the District of Delaware stated that the patents in contention, those covering Teva's multiple sclerosis treatment Copaxone, were not valid. Teva said it plans to appeal the decision. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/24/2017 15:39:20

    Tesco faces new legal action over accounting scandal

    Britain's biggest retailer Tesco PLC (TSCDF) is facing a new claim for damages from an investor about its 2014 profit overstatement, the company said on Tuesday. A spokesman for the supermarket group said it was aware of a claim filed by Manning & Napier, the U.S. fund manager, and would be filing a defense shortly. Manning & Napier declined to comment.

  • 01/24/2017 15:38:49

    UPDATE 2-Nortel cleared to end bankruptcy, distribute $7 bln to creditors

    WILMINGTON, Del., Jan 24 (Reuters) - Judges in Delaware and Canada approved on Tuesday a plan to pay more than $7 billion to creditors of Nortel Networks, ending years of litigation over the former telecommunications company that filed for bankruptcy in 2009.

  • More trends:

    Axcelis Technologies, Inc.ACLS | Axion Power International, Inc.AXPW | Axion Power International, Inc.AXPWW | AxoGen, Inc.AXGN | AXT IncAXTI | B Communications Ltd.BCOM | B. Riley Financial, Inc.RILY | B.O.S. Better Online SolutionsBOSC | B/E Aerospace, Inc.BEAV | Baidu, Inc.BIDU-0.62% |